Chondrex, a new marker of joint disease and hepatic fibrosis;Le chondrex, marqueur du cartilage articulaire et de la fibrose hepatique

Immuno-Analyse et Biologie Specialisee

Volumn 15, Issue 2, 2000, Pages 114-117

  Silva, M ^a   Cauliez, B ^a   Daragon, A ^b   Le Loet, X ^b   Goria, O ^a   Lerebours, E ^a   Lavoinne, A ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

^b Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

Chondrex; Cirrhosis; Joint diseases

Indexed keywords

GLYCOPROTEIN;

ALCOHOL LIVER CIRRHOSIS; ARTHROPATHY; ARTICLE; LIVER FIBROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 0034159837     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0923-2532(00)89077-8     Document Type: Article

References (9)

1. Rejman J, Hurley W. Isolation and characterisation of a novel 39 kDa whey protein from bovine mammary secretions collected during the non-lactating period. Biochem Biophys Res Commun 1998; 150 : 329-334
2. Nyirkos P, Golds E. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J 1990; 269 : 265-268
3. Johansen J S, Williamson M K, Rice J S, Price P A. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992; 7 : 501-512
4. Hakala B E, White C, Recklies A D. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993; 268 : 25803-25810
5. Harvey S, Weisman M, O'Dell J, Scott T, Krusemeier M, Visor J, Swindlehurst C. Chondrex: New marker of joint disease. Clin Chem 1998; 44 : 509-516
6. Johansen J S, Jensen H S, Price P A. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Brit J Rheumatol 1993; 32 : 949-955
7. Johansen J S, Hvolris J, Hansen M. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthristis or trauma of the knee joint. Brit J Rheumatol 1996; 553-559
8. Johansen J S, Stoltenberg M, Hansen M, Florescu A, Horsley-Petersen K, Lorenzen I, Price P A. Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity. Rheumatology 1999; 38 : 618-626
9. Johansen J S, Moller S. Plasma YKL-40: A new potential marker of fibrosis in patients with alcoholic cirrhosis? Scand J Gastroenterol 1997; 32 : 582-590